c-myc and c-myb expression in acute myelogenous leukemia
- 1 October 1992
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 16 (10) , 1003-1011
- https://doi.org/10.1016/0145-2126(92)90080-q
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The treatment of patients with newly diagnosed poor prognosis acute myelogenous leukaemia: response to treatment and treatment failureBritish Journal of Haematology, 1991
- Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cellsBlood, 1991
- Nuclear oncoprotein expression as a function of lineage, differentiation stage, and proliferative status of normal human hematopoietic cellsBlood, 1989
- Protooncogene expression and the clinical characteristics of acute nonlymphocytic leukemia: A Leukemia Intergroup pilot studyBlood, 1989
- Regulation of C-myc expression during growth and differentiation of normal and leukemic human myeloid progenitor cells.Journal of Clinical Investigation, 1986
- Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.Molecular and Cellular Biology, 1985
- Changes in the characteristics of the bone marrow during therapy for acute non-lymphocytic leukemia: Relationship to response to remission induction therapyEuropean Journal of Cancer and Clinical Oncology, 1985
- Oncogene expression in human leukemiaBlood, 1984
- Recognition of drug resistance during remission induction therapy for acute non-lymphocytic leukemia: Utility of day 6 bone marrow biopsyLeukemia Research, 1983
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976